Jan Cerny to Neoplasm, Residual
This is a "connection" page, showing publications Jan Cerny has written about Neoplasm, Residual.
Connection Strength
0.234
-
Patel SA, Litzow MR, Cerny J. Targeted and cytotoxic therapies as maintenance treatment for non-transplant eligible patients with acute myeloid leukemia. Blood Rev. 2021 11; 50:100863.
Score: 0.183
-
Cerny J, Slavickova A, Krepelova A, Trneny M, Klener P. Chemotherapy alone may lead to a PCR negative stem cell harvest in transformed lymphoma refractory to rituximab. Haematologica. 2003 Mar; 88(3):ECR06.
Score: 0.051